US 10,947,308 · Application 16/316,925 · Granted Mar 16, 2021
US 10,947,308
Composition for treatment of disorders
Estimated expiration
October 1, 2037
11y 26d remaining
- Could not fetch continuity data for application PCTGB2017052021: Resource not found (404)
Earliest effective filing
Jul 10, 2017
+ 20 years
Jul 10, 2037
PTA +83d
Oct 1, 2037
No TD
—
Final
Oct 1, 2037
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- January 10, 2019
- Earliest effective filing
- July 10, 2017
- Issue date
- March 16, 2021
- PTA
- +83 days
- Base expiry (before PTA)
- July 10, 2037
July 10, 2017 + 20 years = July 10, 2037 + 83 PTA days = October 1, 2037
- National stage entry of application PCTGB2017052021, filed Jul 10, 2017
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/316,925 · US 10,947,308
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 10,947,308: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10947308Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.